Neuroendovascular Coil Global Market Report 2026

A neuroendovascular coil is a slender wire that is introduced into blood vessels to obstruct or redirect blood flow in the affected area, facilitating clot formation and preventing further complications. This medical device is primarily employed in the treatment of cerebral aneurysms and other vascular abnormalities.

The key product types within the realm of neuroendovascular coils include Guglielmi detachable coils (GDCs) and matrix coils. Guglielmi detachable coils (GDCs) serve as medical devices utilized in endovascular procedures to address cerebral aneurysms. They work by filling the aneurysm with detachable platinum coils, promoting clotting and averting the risk of rupture. These coils find application in various indications, encompassing both ruptured and unruptured aneurysms. Additionally, GDCs are employed for diverse purposes such as tumor surgery and medical teaching, with end users including hospitals, ambulatory surgical centers (ASCs), stroke centers, and other medical facilities.

Tariffs are influencing the neuroendovascular coil market by increasing costs of imported platinum alloys, precision manufacturing equipment, microcatheters, and imaging-compatible materials. Hospitals and stroke centers in North America and Europe are most affected due to reliance on imported high-precision devices, while Asia-Pacific faces higher production costs for export-oriented manufacturing. These tariffs are increasing procedural costs and impacting device pricing. However, they are also encouraging localized manufacturing, regional supplier diversification, and innovation in cost-efficient neurovascular devices.

The neuroendovascular coil market research report is one of a series of new reports from The Business Research Company that provides neuroendovascular coil market statistics, including neuroendovascular coil industry global market size, regional shares, competitors with a neuroendovascular coil market share, detailed neuroendovascular coil market segments, market trends and opportunities, and any further data you may need to thrive in the neuroendovascular coil industry. This neuroendovascular coil market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neuroendovascular coil market size has grown strongly in recent years. It will grow from $1.39 billion in 2025 to $1.49 billion in 2026 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to increasing incidence of cerebral aneurysms, advancements in endovascular treatment techniques, growth in neurointerventional procedures, expansion of stroke treatment centers, improved clinician expertise in neurovascular care.

The neuroendovascular coil market size is expected to see strong growth in the next few years. It will grow to $1.96 billion in 2030 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to increasing adoption of next-generation embolization devices, rising investments in neurovascular research, expansion of minimally invasive treatment options, growing demand for safer aneurysm management, increasing focus on personalized neurointerventional care. Major trends in the forecast period include increasing adoption of advanced detachable coil designs, rising use of flow-diverter and matrix coils, growing demand for minimally invasive neurovascular procedures, expansion of high-precision coil deployment techniques, enhanced focus on long-term treatment outcomes.

The increasing prevalence of neurovascular diseases is anticipated to drive the growth of the neuroendovascular coil market in the coming years. Neurovascular diseases impact the blood vessels that supply the nervous system and frequently result in neurological symptoms and complications. The rise in neurovascular disease prevalence is largely attributed to an aging population, as older individuals are more prone to conditions such as strokes and aneurysms, thereby increasing the overall disease burden. Neuroendovascular coils are utilized in the treatment of neurovascular diseases by being deployed within blood vessels to occlude or stabilize abnormal vascular structures, thereby lowering the risk of bleeding and other related complications. For example, in March 2025, according to a report released by the Stroke Association, a UK-based charity supporting stroke care, the UK had approximately 1.3 million stroke survivors in 2024, with this figure projected to rise to 2.1 million by 2035. Therefore, the rising prevalence of neurovascular diseases is contributing to the growth of the neuroendovascular coil market.

The increasing healthcare expenditure is expected to propel the growth of the neuroendovascular coil market moving forward. Healthcare expenditure encompasses spending on healthcare services, including medical goods, public health activities, and administrative costs. Factors driving this growth include an aging population, technological advancements in medicine, rising pharmaceutical costs, and the increasing prevalence of chronic diseases. The rising healthcare expenditure contributes to advancements in neuroendovascular coil technology, promoting innovation, enhancing accessibility, and improving patient outcomes for treating cerebral aneurysms and vascular disorders. For instance, in June 2024, according to *Health Affairs*, a US-based academic journal, national healthcare expenditure in the U.S. is projected to increase from $4,799.3 billion in 2023 to $5,048.8 billion in 2024, reflecting an increase of around $249.5 billion. As a result, the growing healthcare expenditure is driving the growth of the neuroendovascular coil market.

Major companies operating in the neuroendovascular coil market are emphasizing technological advancements, such as shape-configured, adaptive embolization coils, which allow accurate vessel wall contact, controlled placement, and dense occlusion within small and complex neurovascular anatomies. Shape-configured, adaptive embolization coils utilize specialized geometries and anchoring mechanisms to conform to vessel structures, enhance occlusion efficiency, and enable sequential filling with complementary coils, thereby improving procedural precision and stability when treating intracranial aneurysms and other neurovascular conditions. For example, in October 2025, Penumbra, a US-based neurovascular medical device company, introduced the SwiftSET Neuro Embolization Coil. This coil features a 0.135-inch primary diameter, a shape-optimized design for effective vessel wall apposition, and an anchoring mechanism that enables physicians to establish an initial anchor and subsequently fill with space-seeking SwiftPAC coils, delivering precise, controlled, and secure embolization in small or tortuous vessels.

Major companies operating in the neuroendovascular coil market are Johnson & Johnson Services Inc., Medtronic PLC, Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Kaneka Neurovascular USA, W.L. Gore & Associates Inc., Merit Medical Systems Inc., MicroPort Scientific Corporation, Penumbra Inc., MicroVention Inc., Medikit Co. Ltd., Balt USA LLC, Acandis GmbH, Rapid Medical Ltd., Shape Memory Medical Inc., Wuhan HNC Technology Co. Ltd., Intratech Medical Inc., Phenox GmbH, Cerenovus, Svelte Medical Systems

North America was the largest region in the neuroendovascular coil market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neuroendovascular coil market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the neuroendovascular coil market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The neuroendovascular coil market consists of sales of push able coils, framed coils, complex-shaped coils, micro coils, macro coils, guidewires (used in conjunction with coils), and catheters. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neuroendovascular Coil Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses neuroendovascular coil market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neuroendovascular coil ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neuroendovascular coil market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Guglielmi Detachable Coils (GDCs); Matrix Coils
• 2) By Indication: Ruptured Aneurysm; Unruptured Aneurysm
• 3) By Application: Medical Teaching; Cerebral Aneurysm Treatment; Other Vascular Abnormalities
• 4) By End User: Hospitals; Ambulatory Surgical Centers (ASCs); Stroke Centers; Other End Users
• Subsegments:
• 1) By Guglielmi Detachable Coils (GDCs): Soft GDCs; Standard GDCs; Detachable GDCs With Various Configurations
• 2) By Matrix Coils: Soft Matrix Coils; Coated Matrix Coils; Detachable Matrix Coils; Flow Diverter Matrix Coils
• Companies Mentioned: Johnson & Johnson Services Inc.; Medtronic PLC; Stryker Corporation; Boston Scientific Corporation; Terumo Corporation; Kaneka Neurovascular USA; W.L. Gore & Associates Inc.; Merit Medical Systems Inc.; MicroPort Scientific Corporation; Penumbra Inc.; MicroVention Inc.; Medikit Co. Ltd.; Balt USA LLC; Acandis GmbH; Rapid Medical Ltd.; Shape Memory Medical Inc.; Wuhan HNC Technology Co. Ltd.; Intratech Medical Inc.; Phenox GmbH; Cerenovus; Svelte Medical Systems
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.